Screener
TG Therapeutics TGTX Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's total cost of revenue?
- TG Therapeutics (TGTX) reported total cost of revenue of $41.19M in Q2 2026.
- How has TG Therapeutics's total cost of revenue changed year-over-year?
- TG Therapeutics's total cost of revenue increased by 117.5% year-over-year, from $18.94M to $41.19M.
- What is the long-term trend for TG Therapeutics's total cost of revenue?
- Over 2 years (2023 to 2025), TG Therapeutics's total cost of revenue has grown at a 167.0% compound annual growth rate (CAGR), from $14.13M to $100.71M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about TG Therapeutics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude